首页> 美国卫生研究院文献>Leukemia Research Reports >Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

【2h】

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

机译：急性髓性白血病患者的血液 - 与最小残留疾病的预后价值和相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Clinical characteristics of the population (n = 97). Statistics: frequency (%), median (range).

机译：人口的临床特征（n = 97）。统计：频率（％），中位数（范围）。

著录项

期刊名称 Leukemia Research Reports
作者
Rita Tavarozzi; Enrica Manzato; Riccardo Morganti; Paola Sammuri; Giulia Tarrini; Federica Ricci; Giordana Mattana; Sara Galimberti; Mario Petrini; Giovanni Carulli;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 3
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease [J] . Rita Tavarozzi, Enrica Manzato, Riccardo Morganti, Leukemia Research Reports . 2021,第a期

机译：急性髓性白血病患者的血清 - 与最小残留疾病的预后价值和相关性
2. Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party ( ALWP ALWP ) of the European Society for Blood and Marrow Transplantation ( EBMT EBMT ) [J] . Canaani Jonathan, Labopin Myriam, Huang Xiao J., British Journal of Haematology . 2018,第3期

机译：最小的残留疾病状态预测急性髓性白血病患者进行T细胞急性肝硬化术术患者的结果。欧洲血液和骨髓移植社会急性白血病职能党（ALWP ALWP）分析（EBMT EBMT）
3. Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia [J] . TerwijnM., KelderA., SnelA.N., International journal of laboratory hematology . 2012,第4期

机译：最小残留病检出率定义为总原始干细胞区室的恶性部分，可提供急性髓样白血病的其他预后信息
4. Design of optimal disease and patient-specific chemotherapy protocols for the treatment of Acute Myeloid Leukaemia (AML) [C] . E. Pefani, N. Panoskaltsis, A. Mantalaris International Symposium on Process Systems Engineering . 2012

机译：用于治疗急性髓性白血病（AML）的最佳疾病和患者特异性化疗方案的设计
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels [O] . Daniel A. Pollyea, Holbrook E. Kohrt, Bing Zhang, -1

机译：2-羟基戊二酸在IDH突变急性髓细胞白血病：预测与患者应答微小残留病和相关性甲基胞嘧啶和羟甲水平
7. Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplan [O] . Jonathan Canaani, Myriam Labopin, Xiao J. Huang, 2018

机译：最小的残留疾病状态预测急性髓性白血病患者进行T细胞急性肝硬化术术患者的结果。欧洲血液和骨髓转机急性白血病工作党（ALWP）分析

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

摘要

著录项

相似文献

相关主题

期刊订阅